Trans-dominant inhibition of integrin function

被引:151
作者
DiazGonzalez, F
Forsyth, J
Steiner, B
Ginsberg, MH
机构
[1] F HOFFMANN LA ROCHE & CO LTD, DIV PHARMA, PRECLIN RES, CH-4002 BASEL, SWITZERLAND
[2] Scripps Res Inst, DEPT VASC BIOL, LA JOLLA, CA 92037 USA
关键词
D O I
10.1091/mbc.7.12.1939
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Occupancy of integrin adhesion receptors can alter the functions of other integrins and cause partition of the ligand-occupied integrin into focal adhesions. Ligand binding also changes the conformation of integrin extracellular domains. To explore the relationship between ligand-induced conformational change and integrin signaling, we examined the effect of ligands specific for integrin alpha(IIb)beta(3) on the functions of target integrins alpha(5) beta(1) and alpha(2) beta(1). We report that binding of integrin-specific ligands to a suppressive integrin can inhibit the function of other target integrins (trans-dominant inhibition). Trans-dominant inhibition is due to a blockade of integrin signaling. Furthermore, this inhibition involves both a conformational change in the extracellular domain and the presence of the beta cytoplasmic tail in the suppressive integrin. Similarly, ligand-induced recruitment of alpha(IIb)beta(3) to focal adhesions also involves a conformational rearrangement of its extracellular domain. These findings imply that the ligand-induced conformational changes can propagate from an integrin's extracellular to its intracellular face. Trans-dominant inhibition joy integrin ligands may coordinate integrin signaling and can lead to unexpected biological effects of integrin-specific inhibitors.
引用
收藏
页码:1939 / 1951
页数:13
相关论文
共 57 条
  • [1] LOW-MOLECULAR-WEIGHT, NONPEPTIDE FIBRINOGEN RECEPTOR ANTAGONISTS
    ALIG, L
    EDENHOFER, A
    HADVARY, P
    HURZELER, M
    KNOPP, D
    MULLER, M
    STEINER, B
    TRZECIAK, A
    WELLER, T
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (23) : 4393 - 4407
  • [2] INTEGRIN BETA-3 CYTOPLASMIC TAIL IS NECESSARY AND SUFFICIENT FOR REGULATION OF ALPHA(5)BETA(1) PHAGOCYTOSIS BY ALPHA(V)BETA(3) AND INTEGRIN-ASSOCIATED PROTEIN
    BLYSTONE, SD
    LINDBERG, FP
    LAFLAMME, SE
    BROWN, EJ
    [J]. JOURNAL OF CELL BIOLOGY, 1995, 130 (03) : 745 - 754
  • [3] INTEGRIN ALPHA(V)BETA(3) DIFFERENTIALLY REGULATES ADHESIVE AND PHAGOCYTIC FUNCTIONS OF THE FIBRONECTIN RECEPTOR ALPHA(5)BETA(1)
    BLYSTONE, SD
    GRAHAM, IL
    LINDBERG, FP
    BROWN, EJ
    [J]. JOURNAL OF CELL BIOLOGY, 1994, 127 (04) : 1129 - 1137
  • [4] LIGAND-DEPENDENT AND LIGAND-INDEPENDENT INTEGRIN FOCAL CONTACT LOCALIZATION - THE ROLE OF THE ALPHA-CHAIN CYTOPLASMIC DOMAIN
    BRIESEWITZ, R
    KERN, A
    MARCANTONIO, EE
    [J]. MOLECULAR BIOLOGY OF THE CELL, 1993, 4 (06) : 593 - 604
  • [5] ASSEMBLY AND FUNCTION OF INTEGRIN RECEPTORS IS DEPENDENT ON OPPOSING ALPHA-CYTOPLASMIC AND BETA-CYTOPLASMIC DOMAINS
    BRIESEWITZ, R
    KERN, A
    MARCANTONIO, EE
    [J]. MOLECULAR BIOLOGY OF THE CELL, 1995, 6 (08) : 997 - 1010
  • [6] REQUIREMENT OF VASCULAR INTEGRIN ALPHA(V)BETA(3) FOR ANGIOGENESIS
    BROOKS, PC
    CLARK, RAF
    CHERESH, DA
    [J]. SCIENCE, 1994, 264 (5158) : 569 - 571
  • [7] ANTIINTEGRIN ALPHA-V-BETA-3 BLOCKS HUMAN BREAST-CANCER GROWTH AND ANGIOGENESIS IN HUMAN SKIN
    BROOKS, PC
    STROMBLAD, S
    KLEMKE, R
    VISSCHER, D
    SARKAR, FH
    CHERESH, DA
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (04) : 1815 - 1822
  • [8] MONOCLONAL-ANTIBODIES TO DISTINCTIVE EPITOPES ON THE ALPHA AND BETA SUBUNITS OF THE FIBRONECTIN RECEPTOR
    BROWN, PJ
    JULIANO, RL
    [J]. EXPERIMENTAL CELL RESEARCH, 1988, 177 (02) : 303 - 318
  • [9] SELECTIVE-INHIBITION OF FIBRONECTIN-MEDIATED CELL-ADHESION BY MONOCLONAL-ANTIBODIES TO A CELL-SURFACE GLYCOPROTEIN
    BROWN, PJ
    JULIANO, RL
    [J]. SCIENCE, 1985, 228 (4706) : 1448 - 1451
  • [10] CHEN YP, 1994, J BIOL CHEM, V269, P18307